- Home
- HTGC vs HCM Comparison
HTGC vs HCM Comparison
Compare HTGC & HCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | HTGC | HCM |
|---|---|---|
| Founded | 2003 | 2000 |
| Country | United States | Hong Kong |
| Employees | 50 | 1811 |
| Industry | Investment Managers | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.8B | 2.4B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | HTGC | HCM |
|---|---|---|
| Price | $14.20 | $14.17 |
| Analyst Decision | Buy | Sell |
| Analyst Count | 6 | 1 |
| Target Price | ★ $18.67 | $13.75 |
| AVG Volume (30 Days) | ★ 3.1M | 20.0K |
| Earning Date | 04-30-2026 | 03-05-2026 |
| Dividend Yield | ★ 13.30% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $11.28 | $28.37 |
| Revenue Next Year | $4.83 | $17.50 |
| P/E Ratio | $8.61 | ★ $5.49 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $13.77 | $11.51 |
| 52 Week High | $19.67 | $19.50 |
Technical Indicators
Market Signals| Indicator | HTGC | HCM |
|---|---|---|
| Relative Strength Index (RSI) | 37.49 | 46.46 |
| Support Level | $13.80 | $13.08 |
| Resistance Level | $14.69 | $14.80 |
| Average True Range (ATR) | 0.35 | 0.34 |
| MACD | 0.09 | 0.02 |
| Stochastic Oscillator | 31.12 | 31.84 |
Price Performance
Historical ComparisonAbout HTGC Hercules Capital Inc.
Hercules Capital Inc is a specialty finance company focused on providing senior secured loans to high-growth, venture capital-backed, and institutional-backed companies in a variety of technology and life sciences industries. The company's primary business objectives are to increase its net income, net investment income, and net asset value (NAV) through its investments mainly in structured debt or senior secured debt instruments of venture capital-backed and institutional-backed companies across a variety of technology-related industries at attractive yields. It finances companies belonging to computer software and hardware, networking systems, semiconductors, medical devices, bio-pharmaceutical, and other related sectors.
About HCM HUTCHMED (China) Limited
HUTCHMED (China) Ltd is an biopharmaceutical company engaged in the discovery, development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has a portfolio of several cancer drug candidates currently in clinical studies around the world and extensive commercial infrastructure in its home market of China. The company operates in two reportable segments Oncology/Immunology, and Other Ventures.